Related Experiment Video
Updated: Sep 28, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control
Jordan L Lacoste1, Thomas W Szymanski2, Juan Carlo Avalon3
1Department of Pharmacy, WVU Medicine, 1 Medical Center Drive, Morgantown, WV, 26505, USA. Jordan.Lacoste.m@wvumedicine.org.
Insights
Atrial fibrillation (AF) management focuses on stroke prevention and symptom control. Newer evidence supports rhythm control strategies for newly diagnosed AF patients, potentially reducing adverse cardiovascular events.
Area of Science:
- Cardiology
- Clinical Medicine
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia with increasing incidence due to aging populations and comorbidities.
- AF significantly impacts patient quality of life and increases healthcare resource utilization.
- Effective management is crucial to mitigate these adverse effects.
Purpose of the Study:
- To provide a comprehensive review of atrial fibrillation management.
- To detail the pharmacotherapy for rate and rhythm control strategies in AF.
- To discuss newer data on rhythm control efficacy.
Main Methods:
- Literature review focusing on AF management and pharmacotherapy.
- Analysis of historical and recent clinical data regarding rate and rhythm control.
- Examination of strategies for modulating AF-promoting factors.
Main Results:
- Rate control using beta-blockers and calcium channel blockers has been a traditional initial strategy.
- Emerging data indicate rhythm control with antiarrhythmics or ablation may reduce adverse cardiovascular events, especially in new-onset AF.
- Holistic management includes addressing AF-promoting factors.
Conclusions:
- Rhythm control strategies show promise for reducing major adverse cardiovascular events in newly diagnosed AF.
- Pharmacotherapy for both rate and rhythm control remains central to AF management.
- Comprehensive management, including lifestyle modifications, is essential for patients with AF.
Abstract:
Atrial fibrillation (AF) is an increasingly common arrhythmia encountered in clinical practice that leads to a substantial increase in utilization of healthcare services and a decrease in the quality of life of patients. The prevalence of AF will continue to increase as the population ages and develops cardiac comorbidities; thus, prompt and effective treatment is important to help mitigate systemic resource utilization. Treatment of AF involves two tenets: prevention of stroke and systemic embolism and symptom control with either a rate or a rhythm control strategy. Historically, due to the safe nature of medications like beta-blockers and non-dihydropyridine calcium channel blockers, used in rate control, it has been the initial strategy used for symptom control in AF. Newer data suggest that a rhythm control strategy with antiarrhythmic medications with or without catheter ablation may lead to a reduction in major adverse cardiovascular events, particularly in patients newly diagnosed with AF. Modulation of factors that promote AF or its complications is another important aspect of the overall holistic management of AF. This review provides a comprehensive focus on the management of patients with AF and an in-depth review of pharmacotherapy of AF in the rate and rhythm control strategies.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias VII: Nursing Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

